Clinical Research Management Briefing - December 18, 2017
The 35-site Alzheimer’s Clinical Trial Consortium (ACTC), funded by a nearly $70 million award from the National Institutes of Health (NIH), aims to streamline and innovate the clinical trial process for Alzheimer’s and other dementias.
National Institutes of Health, December 11
With most cancer treatment clinical trials concentrated in large research hospitals, access could be a main driver of low patient participation.
Becker’s Hospital Review, December 11
Despite a proposed delay to the enforcement of the revised Common Rule, most institutions plan to begin complying with the new requirements by January 19, 2018.
New draft guidance from the U.S. Food and Drug Administration (FDA) encourages companies developing drugs for rare pediatric diseases to collaborate on multidrug clinical trials, reducing the number of participants receiving placebos.
FierceBiotech, December 7
The FDA is updating its Bioresearch Monitoring (BIMO) program inspections to improve accuracy, data integrity and research subject safety.
Applied Clinical Trials, December 8
Financial and Operations
Community outreach, patient education and wider access to care are a few ways healthcare organizations are working to rebuild trust with minorities and increase their representation in clinical trials.
Outsourcing-Pharma, December 4
Digital solutions such as social media let researchers forge a more patient-centric approach to clinical trials, reducing recruitment timelines and increasing participant diversity.
The American Journal of Managed Care, December 12